Inovio Pharmaceuticals Inc vs Public Storage — how do they compare? Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M), while Public Storage trades at $324.41 (market cap $60.71B). The key difference: Public Storage is far larger — about 772.9× Inovio Pharmaceuticals Inc's market cap, and Public Storage pays a 3.69% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | PSA | |
|---|---|---|
Market Cap | $78.55M | $60.71B |
Sector | Health | Real Estate |
52-Week High | $2.87 | $330.47 |
52-Week Low | $0.66 | $258.44 |
Enterprise Value | $49.56M | $74.98B |
Dividend Yield | — | 3.69% |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →